Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Epigenomics. 2013 Oct;5(5):10.2217/epi.13.49. doi: 10.2217/epi.13.49

Table 4.

Percentage methylation summary for Avy and CabpIAP loci.

Exposure (ppm) All live pups; % (SD) All male; % (SD) All female; % (SD) a/a pups; % (SD) a/a males; % (SD) a/a females; % (SD) Avy/a pups; % (SD) Avy/a males; % (SD) Avy/a females; % (SD)
CabpIAP (Avy/a and a/a offspring) mean methylation across four CpG sites
0 82.2 (6.7) 82.4 (7.1) 82 (6.3) 82.7 (5.4) 84.2 (4.8) 80.6 (5.7) 81.7 (7.7) 80 (8.9) 82.9 (6.7)
2.1 83.5 (5.7) 82.8 (6.5) 84.3 (4.3) 83.9 (6.7) 83.3 (8.1) 84.7 (4.6) 83 (4.5) 82.3 (4.7) 83.9 (4.1)
16 80.1 (9.4) 79.7 (10.3) 80.9 (7.6) 79.2 (7.6) 79.6 (7.7) 78.8 (7.6) 80.7 (10.7) 79.7 (11.6) 83.7 (6.9)
32 82.7 (4.6) 83.2 (4.8) 82 (4.4) 81.2 (4.2) 81.4 (4.5) 80.9 (3.9) 83.9 (4.7) 84.5 (4.6) 83 (4.8)
Cubic trend p-value 0.01* 0.05* 0.05* 0.01* 0.26 0.01* 0.11 0.12 0.96
Avy (Avy/a offspring) mean methylation across four CpG sites
0 29.5 (24.8) 24.1 (26.1) 33 (23.9)
2.1 40.4 (24.8) 41.3 (21.2) 39.2 (29.4)
16 27.1 (23.1) 24.8 (23.1) 34 (23.1)
32 26.9 (21.8) 29.4 (24.1) 23.4 (18.5)
Cubic trend p-value 0.04* 0.02* 0.85
*

p < 0.05 for the cubic trend.

a/a: Wild-type; Avy: Viable yellow agouti; CabpIAP: CDK5 activator-binding protein intracisternal A particle element; SD: Standard deviation.

HHS Vulnerability Disclosure